AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Biotage

Delisting Announcement • Jul 7, 2025

2894_rns_2025-07-07_5f802511-bbae-481f-98dc-1d8c5ff5a30c.pdf

Delisting Announcement

Open in Viewer

Opens in native device viewer

Delisting of Biotage AB (publ) from Nasdaq Stockholm

Nasdaq Stockholm has decided that Biotage AB (publ) will be delisted from Nasdaq Stockholm. The last day of trading in the share will be on Monday, July 21, 2025.

Contacts

Frederic Vanderhaegen, President & CEO Tel: +41 797600543 [email protected]

About Biotage

Biotage is a global supplier and solutions partner to a wide range of customers within Drug Discovery and Development and Analytical Testing. With expertise in separation and purification technology and leveraging intelligent workflow solutions, the group aims to be the best partner advancing health solutions.

Headquartered in Sweden, Biotage operates globally serving over 80 countries. Biotage is listed on NASDAQ Stockholm (BIOT). Website: www.biotage.com

Attachments

Delisting of Biotage AB (publ) from Nasdaq Stockholm

Talk to a Data Expert

Have a question? We'll get back to you promptly.